Monoclonal antibodies against interleukin-2 receptors in the immunosuppressive management of kidney graft recipients

This publication has 108 references indexed in Scilit:

• Randomized Controlled Trial of a Monoclonal Antibody against the Interleukin-2 Receptor (33B3.1) as Compared with Rabbit Antithymocyte Globulin for Prophylaxis against Rejection of Renal Allografts
  New England Journal of Medicine, 1990
• ANTI-INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT-A PILOT STUDY
  Transplantation, 1989
• Anti-interleukin-2 receptor monoclonal antibody therapy induces anti-idiotypic antibodies in mice that block both in vitro and in vivo activity
  Journal of Autoimmunity, 1988
• Novel interleukin 2 (IL-2) receptor appears to mediate IL-2-induced activation of natural killer cells.
  Journal of Clinical Investigation, 1988
• GENERATION OF CD4-POSITIVE SUPPRESSOR T CELLS FROM MIXED LYMPHOCYTE CULTURES IN THE PRESENCE OF INTERLEUKIN 2 RECEPTOR ANTIBODY TÜ69
  Transplantation, 1987
• Parameters of interaction of a novel monoclonal antibody (33B3.1) with the human IL2-Receptors: Interrelationship between 33B3.1, Anti-Tac, and IL2 binding sites
  Human Immunology, 1987
• Plasma interleukin 2 receptor levels in renal allograft recipients
  Clinical Immunology and Immunopathology, 1987
• A Randomized Clinical Trial of OKT3 Monoclonal Antibody for Acute Rejection of Cadaveric Renal Transplants
  New England Journal of Medicine, 1985
• Characterization of a monoclonal rat anti-mouse interleukin 2 (IL-2) receptor antibody and its use in the biochemical characterization of the murine IL-2 receptor
  Clinical Immunology and Immunopathology, 1985
• REVERSAL OF TRANSPLANT REJECTION BY MONOCLONAL ANTIBLAST ANTIBODY
  The Lancet, 1983